Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Optinose, Inc. is a specialty pharmaceutical company focused on developing and commercializing ENT and allergy treatments. Its flagship product, XHANCE, is a nasal spray utilizing proprietary Exhalation Delivery System technology to deliver corticosteroids deep into nasal passages. The company targets physicians and patients for chronic rhinosinusitis and nasal polyps, emphasizing innovative drug delivery, cost-effective therapies, and expanding into primary care and international markets.
This description was generated via AI from an annual report. Updated about 1 year ago.